Avoidance of treatment interruption: an unrecognized benefit of accelerated radiotherapy in oropharyngeal carcinomas?

被引：0
|
作者：
机构：
来源：
Int J Radiat Oncol Biol Phys | / 1卷 / 41-45期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] RESULTS OF RADIOLOGIC AND COMBINED SURGICAL AND RADIOLOGIC TREATMENT OF OROPHARYNGEAL CARCINOMAS
    WENDT, T
    STRAHLENTHERAPIE, 1981, 157 (06) : 361 - 364
  • [22] Interventions for the treatment of oral cavity and oropharyngeal cancer: radiotherapy
    Glenny, Anne-Marie
    Furness, Susan
    Worthington, Helen V.
    Conway, David I.
    Oliver, Richard
    Clarkson, Jan E.
    Macluskey, Michaelina
    Pavitt, Sue
    Chan, Kelvin K. W.
    Brocklehurst, Paul
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (12):
  • [23] RADIOTHERAPY AS INITIAL TREATMENT FOR CARCINOMAS OF TONSILLAR REGION
    VOLTERRANI, F
    SIGURTA, D
    USLENGHI, C
    CHIESA, F
    MOLINARI, R
    TUMORI, 1982, 68 (02) : 113 - 118
  • [24] Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer
    Price, James M.
    Mistry, Hitesh B.
    Betts, Guy
    Cheadle, Eleanor J.
    Dixon, Lynne
    Garcez, Kate
    Illidge, Tim
    Iyizoba-Ebozue, Zsuzsanna
    Lee, Lip Wai
    McPartlin, Andrew
    Prestwich, Robin J. D.
    Papageorgiou, Savvas
    Pritchard, Dylan J.
    Sykes, Andrew
    West, Catharine M.
    Thomson, David J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (20) : 2203 - +
  • [25] RTtxGap: An android radiobiological tool for compensation of radiotherapy treatment interruption
    Yusoff, A. L.
    Mohamad, M.
    Abdullah, R.
    Bhavaraju, V. M. K.
    Idris, N. R. Nik
    13TH SOUTH-EAST ASIAN CONGRESS OF MEDICAL PHYSICS 2015 (SEACOMP), 2016, 694
  • [26] Conventional radiotherapy versus accelerated hyperfractionated radiotherapy versus conventional radiotherapy and concomitant chemotherapy in advanced oropharyngeal carcinoma: A randomized clinical trial
    Olmi, P
    Fallai, C
    Rossi, E
    Crispino, S
    Marsoni, S
    Torri, V
    Flann, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 420 - 420
  • [27] Is comorbidity associated with interruption of Radiotherapy treatment in patients with HNSCC cancer?
    Abravan, Azadeh
    Osorio, Eliana Vasquez
    Price, James
    van Herk, Marcel
    Mistry, Hitesh
    Price, Gareth
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1195 - S1197
  • [28] Assessment of quality of life in patients treated with accelerated radiotherapy for laryngeal and hypopharyngeal carcinomas
    Allal, AS
    Dulguerov, P
    Bieri, S
    Lehmann, W
    Kurtz, JM
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2000, 22 (03): : 288 - 293
  • [29] Accelerated hyperfractionation in the treatment of esophageal squamous cell carcinomas
    Nishimura, Y
    Okuno, Y
    Hiraoka, M
    Tsutsui, K
    Ono, K
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 280 - 280
  • [30] Molecular profiles used for identification of squamous; cell carcinomas of the supraglottic larynx that benefit of reduced overall treatment time of radiotherapy
    Eriksen, JG
    Buffa, FM
    Alsner, J
    Steiniche, T
    Bentzen, SM
    Overgaard, J
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S44 - S45
12345